United States: The U.S. Court Of Appeals Denies Rehearing On Cuts To 340B Drug Pricing Program - Sheppard Mullin Richter & Hampton

In a setback to hospitals challenging deep cuts to reimbursement for prescription drugs acquired through the 340B drug pricing program ("340B Program"), the U.S. Court of Appeals for the District...